The global self-sampling blood collection and storage devices market was valued at USD 192.4 million in 2024 and is projected to reach USD 423.5 million by 2035. The industry is expected to grow at a steady CAGR of 7.5% from 2025 to 2035, driven by increasing demand for at-home diagnostic solutions, rising awareness of preventive healthcare, and advancements in user-friendly blood collection technologies.

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77529

Market Overview

Demand for remote and patient-collected samples is on the rise as a consequence of longstanding needs: equitable access for underserved populations, relief from phlebotomy services, and support for decentralized clinical trials involving larger and more diverse cohorts.

Methodological improvements with things like precision volumetric sampling, passive plasma separation, and simplified collection workflows minimize pre-analytical variability, and the prospect of shipping remote specimens is becoming more palatable for central laboratories.

Regulatory momentum and increasing clarity around the validation of microsamples reduce barriers to clinical and diagnostic use, while innovations in logistics – stabilizers for storage formats and validated transportation media – enhance integration with supply chain logistics.

Analysts’ Viewpoint on the Global Self-sampling Market

The market for self-collected, self-collected blood collection and storage products is evolving from a niche convenience product to a key enabler for decentralized diagnostics and virtual clinical trials. There is a growing interest in patient-centric care, provided by advancements in volumetric microsampling, improved methods for standardization of dried blood spots (DBS), and supply chains that are streamlined and integrated into a clinical laboratory, which are prompting laboratories and sponsors to review workflow and methods for remote collection of samples while maintaining a chain of custody.

Established manufacturers and dedicated medtech companies are expediting the development and combination of commercially available products to minimize analytical variability, pre-analytical stability, and regulatory compliance for buyers, thereby allowing for risk mitigation and openness of acceptance for clinical use.

Analysis of Key Players

The landscape is a mix of established diagnostic giants and innovative “MedTech” startups focusing on pain reduction and sample stability.

Leading companies operating in the global market include:

• Neoteryx, LLC.
• DBS System SA
• PanoHealth
• Tasso, Inc
• Seventh Sense Biosystems
• LAMEDITECH
• Capitainer
• Spot On Sciences
• Trajan Scientific and Medical
• Drawbridge Health
• Weavr Health
• Microdrop
• Hemex Health
• Eastern Business Forms, Inc
• YourBio Health
• Other Prominent Players

Strategic efforts in 2026 are focused on Laboratory Integration, ensuring that self-collected samples are compatible with automated high-throughput analyzers at major labs like Quest and LabCorp.

Recent Developments in Self-sampling Devices

• In September 2025, Trajan Scientific and Medical’s hemaPEN device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the clinical setting, to drive information-rich healthcare decision-making.
• In February 2025, IHI announced its “Project‑COMFORT” – a collaborative project with ~51 organisations to make microsampling (home self-collection of less than 0.5 mL blood) standard in healthcare/clinical-research contexts.
• In March 2024, U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to RedDrop Dx’s RedDrop One blood collection device for prescription use. This approval is a milestone for RedDrop Dx, an Innosphere Ventures Client Company, signifying a leap forward in blood collection technology and patient care

👉 Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77529

Key Market Trends & Strategies

🩹 The “Pain-Free” Revolution

• Push-Button Adoption: Devices that use micro-needles or vacuum technology are seeing 2x growth compared to traditional manual lancets.
• Laser Lancing: Startups are introducing laser-based “prickers” that eliminate the fear of needles entirely.

📈 Market Challenges

• Sample Integrity Concerns: Incorrect user handling can lead to a 15-20% variation in accuracy. Manufacturers are countering this with AI-guided mobile apps that “watch” the user during collection.
• Regulatory Patchwork: While the US and Europe have clear pathways, markets like Japan and India are still refining their home-diagnostic approval frameworks.

🌟 Growth Opportunities

• Remote Pediatric Care: High demand for “at-home” kits for infants to avoid the trauma of hospital-based venous draws.
• Pharma R&D: Using self-sampling for “Pharmacokinetics” (PK) studies to monitor how drugs are processed in real-world settings over 24-hour periods.

Market Segmentation

By Product

• Collection Kits (~60% Share)
• DBS Cards / Microsampling Devices
• Lancets & Accessories

By Application

• Diagnostic Testing (46% Share)
• Chronic Disease Monitoring
• Genomic & Infectious Disease Testing

By End-User

• Diagnostic Laboratories (38% Share)
• Home-Based Users (Fastest Growth)
• Biobanks & CROs

Regional Outlook

• North America: The largest revenue contributor (US$ 87M+ in base year). Dominated by the US due to the high prevalence of diabetes and a robust direct-to-consumer (DTC) testing market.
• Europe: Driven by Universal Healthcare mandates to reduce the burden on phlebotomy clinics. The UK and Germany are lead adopters of “post-kit” diagnostic pathways.
• Asia-Pacific: Projected to record the fastest development through 2033. Rising disposable incomes and a critical shortage of healthcare professionals in rural areas make self-sampling a logical infrastructure solution.

Conclusion

The Self-sampling Blood Collection market in 2026 is the backbone of the “Hospital-at-Home” movement. By removing the needle and the clinic from the diagnostic equation, these devices are empowering a new era of proactive, patient-led healthcare. For stakeholders, the opportunity lies in Digital Ecosystems—not just selling the device, but the integrated app, the lab logistics, and the AI-interpreted result.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=77529&ltype=S

FAQs

• How big was the global self-sampling blood collection and storage devices market in 2024?

The global self-sampling blood collection and storage devices market was valued at US$ 192.4 Mn in 2024

• How big will the global self-sampling blood collection and storage devices industry be in 2035?

The global self-sampling blood collection and storage devices industry is projected to reach more than US$ 423.5 Mn by the end of 2035

• What are the factors driving the self-sampling blood collection and storage devices market?

Technological innovation in volumetric and stabilization methods and strategic partnerships and laboratory integrations

• What will be the CAGR of the global self-sampling blood collection and storage devices industry during the forecast period?

The CAGR is anticipated to be 7.5% from 2025 to 2035

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact:

 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com